Centre for Organ Transplantation

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


550 publications

... | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 1991 | 1988 |
 
Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
Ciuffreda D., Codarri L., Buhler L., Vallotton L., Giostra E., Mentha G., Morel P., Pantaleo G., Pascual M., 2010. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society, 16 (1) pp. 49-55.
 
Identification of biomarkers for Fabry disease by urine proteomics
Kistler A.D., Mischak H., Breunig F., Hughes D.A., Barbey F., Wuthrich R.P., Serra A.L., 2010. p. 62 dans 9th International Symposium on Lysosomal Storage Diseases, International Journal of Clinical Pharmacology and Therapeutics. Peer-reviewed.
 
Impact of standardised review of intravenous antibiotic therapy 72 hours after prescription in two internal medicine wards.
Manuel Oriol, Burnand Bernard, Bady Pierre, Kammerlander Raoul, Vansantvoet Maria, Francioli Patrick, Zanetti Giorgio, 2010. Journal of Hospital Infection, 74 (4) pp. 326-331. Peer-reviewed.
 
Infection and chronic allograft dysfunction.
Dupont P.J., Manuel O., Pascual M., 2010. Kidney International. Supplement, 78 (119) pp. S47-S53.
 
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.
Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Snydman D.R., Allen U., Humar A., Transplantation Society International CMV Consensus Group, 2010. Transplantation, 89 (7) pp. 779-795.
 
Kidney transplant patients
Manuel Oriol, Baid-Agrawal Seema, Pascual Manuel, 2010. pp. 866-870 dans Cohen J., Opal S.M., Powderly W.G. (eds.) Infectious Diseases chap. 80, Mosby.
 
Natural killer cell receptor-repertoire and functions after induction therapy by polyclonal rabbit anti-thymocyte globulin in unsensitized kidney transplant recipients.
Hadaya K., Avila Y., Valloton L., de Rham C., Bandelier C., Ferrari-Lacraz S., Pascual M., Pantaleo G., Martin P.Y., Buhler L. et al., 2010. Clinical Immunology, 137 (2) pp. 250-260.
 
Polykystose hépatorénale: développements récents [Recent insights into polycystic kidney disease]
Bonny O., Chehade H., Fellmann F., Qanadli S.D., Barbey F., 2010. Revue Médicale Suisse, 6 (238) pp. 454-459.
 
Prevalence of anti-HLA antibodies after liver transplantation.
Fontana M., Moradpour D., Aubert V., Pantaleo G., Pascual M., 2010. Transplant International, 23 (8) pp. 858-859.
 
Recurrent Hepatitis C After Liver Transplantation Experience of the First 21 Patients Treated in Lausanne
Antonino Anca T., Fontana Massimiliano, Giostra Emiliano, Pascual Manuel, Moradpour Darius, 2010. pp. 20S dans Annual Meeting of the Swiss Society of Gastroenterology, Swiss Society for Visceral, Surgery Swiss Association for the Study of the Liver, Swiss Association of Clinical Nutrition, Swiss Medical Weekly. Peer-reviewed.
 
Risk of Bronchiolitis Obliterans Syndrome Is Twice as High in Cyclosporine Treated Patients in Comparison to Tacrolimus 3 Years after Lung Transplantation: Results of a Prospective Randomized International Trial of 248 Patients
Treede H., Glanville A., Klepetko W., Lama R., Bravo C., Estenne M., Aubert JD., Aboyoun C., Reichenspurner H., 2010. p. 39 dans 30th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation, Journal of Heart and Lung Transplantation. Peer-reviewed.
Scoring system for renal pathology in Fabry disease: report of the international study group of fabry nephropathy (ISGFN).
Fogo Agnes B., Bostad Leif, Svarstad Einar, Cook William J., Moll Solange, Barbey Federic, Geldenhuys Laurette, West Michael, Ferluga Dusan, Vujkovac Bojan et al., 2010. Nephrology, Dialysis, Transplantation, 25 (7) pp. 2168-2177.
 
Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient.
Mani L.Y., Nseir G., Venetz J.P., Pascual M., 2010. Transplantation, 90 (7) pp. 804-805.
 
Strategies for preventing late-onset cytomegalovirus disease in organ transplant recipients.
Manuel O, Pascual M., 2010. Trends in Transplantation, 4 (1) pp. 36-44.
 
Survival impact of lung transplantation for COPD.
Lahzami S., Bridevaux P.O., Soccal P.M., Wellinger J., Robert J.H., Ris H.B., Aubert J.D., 2010. European Respiratory Journal, 36 (1) pp. 74-80.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2010. pp. 35-39 dans Grinyo J.M., Vulto A.G. (eds.) Transplantation for European hospital pharmacists, Pharma Publishing and Media Europe.
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning.
Pilat N., Baranyi U., Klaus C., Jaeckel E., Mpofu N., Wrba F., Golshayan D., Muehlbacher F., Wekerle T., 2010. American Journal of Transplantation, 10 (4) pp. 751-762.
Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.
Perrottet Nancy, Manuel Oriol, Lamoth Frederic, Venetz Jean-Pierre, Sahli Roland, Decosterd Laurent A., Buclin Thierry, Pascual Manuel, Meylan Pascal, 2010. BMC Infectious Diseases, 10 p. 2.
Swiss clinical practice guidelines for skin cancer in organ transplant recipients.
Hofbauer G.F., Anliker M., Arnold A., Binet I., Hunger R., Kempf W., Laffitte E., Lapointe A.C., Pascual M., Pelloni F. et al., 2009/07/25. Swiss medical weekly, 139 (29-30) pp. 407-415. Peer-reviewed.
 
Transplantation tolerance: from bench to bedside
Dela Golshayan, Manuel Pascual, 2009/04/01. Trends Transplant, 3 (1) pp. 3-12. Peer-reviewed.
 
An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants.
Manuel O., Pang X.L., Humar A., Kumar D., Doucette K., Preiksaitis J.K., 2009. Journal of Infectious Diseases, 199 (11) pp. 1621-1628. Peer-reviewed.
 
Anti-CD154 mAb and rapamycin induce T regulatory cell mediated tolerance in xenogeneic islet transplantation : IXA-O-1.2
Muller Yannick, Morel Philippe, Golshayan Déla, Seebach Jörg, Wekerle Thomas, Bühler Léo, 2009. p. 353 dans Joint Meeting of the International-Pancreas-and-Islet-Transplant-Association/International-Xenotransplantation-Association, Xenotransplantation. Peer-reviewed.
 
Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Transplantation, 87 (12) pp. 1897-1898.
 
Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.
Kumar D., Chernenko S., Moussa G., Cobos I., Manuel O., Preiksaitis J., Venkataraman S., Humar A., 2009. American Journal of Transplantation, 9 (5) pp. 1214-1222.
Die Schweizerische Transplantationskohortenstudie (STCS)
Kohler M., van Delden C., Pascual M., Müller N., Baumann P., Steiger J., 2009. Schweizerische Ärztezeitung, 90 (24) pp. 953-955.
 
Donor's and organ representations in liver, kidney, heart and lung transplantation : a qualitative longitudinal study
Bosisio F., Bridy C., Pralong L., Szymanski J., Pascual M., Piot-Ziegler C., 2009. pp. 225-225 dans Abstracts of the 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
 
Donors/recipients representations about living-kidney donation : P-527
Pralong L., Pascual M., Santiago M., Venetz J.P., Piot-Ziegler C., 2009. p. 226 dans 14th Congress of the European Society for Organ Transplantation, Transplant International. Peer-reviewed.
 
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data.
Mehta A., Beck M., Elliott P., Giugliani R., Linhart A., Sunder-Plassmann G., Schiffmann R., Barbey F., Ries M., Clarke J.T. et al., 2009. Lancet, 374 (9706) pp. 1986-1996. Peer-reviewed.
 
Existential values transformation in all organ transplantation : a qualitative prospective study
Piot-Ziegler C., Ruffiner.Boner N. , Cuttelod T., Fonjallaz F., Pilon N., Pascual M., 2009. p. 317 dans From Knowledge to Interventions, 23rd Annual Conference of the European Health Psychology Society (EHPS), Psychology and Health. Peer-reviewed.
 
Fabry disease affecting thoracic aorta
Rolf F., Barbey F., Brakch N., Rizzo E., Jeanrenaud X., Kamel E., Qanadli S.D., 2009. dans USSMV 2009, 10th Annual Meeting of the Union of Vascular Societies of Switzerland.
 
Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplant recipients: a prospective study : P125
Manuel O., Pascual M., Perrottet N., Lamoth F., Venetz J.P., Decosterd L., Buclin T., Meylan P., 2009. pp. 32S-33S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Ganciclovir Exposure under a 450 mg Daily Dosage of Valganciclovir for the Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients.
Manuel Oriol, Pascual Manuel, Perrottet Nancy, Lamoth Frederic, Venetz Jean-Pierre, Decosterd Laurent, Buclin Thierry, Meylan Pascal R., 2009. p. 249 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
High Specificity of C4d/CD68 Staining for the Diagnosis of Late Antibody-Mediated Rejection in Heart Transplantation.
Yerly Patrick, Rotmann Samuel, Hullin Roger, von Segesser Ludwig, Pascual Manuel, 2009. p. 656 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients.
Hadaya K., Ferrari-Lacraz S., Giostra E., Majno P., Moll S., Rubbia-Brandt L., Marangon N., Venetz J.P., Bolle J.F., Mentha G. et al., 2009. Transplant International, 22 (2) pp. 242-246. Peer-reviewed.
 
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
Manuel O., Asberg A., Pang X., Rollag H., Emery V.C., Preiksaitis J.K., Kumar D., Pescovitz M.D., Bignamini A.A., Hartmann A. et al., 2009. Clinical Infectious Diseases, 49 (8) pp. 1160-1166.
 
L'hypertension chez les transplantés d'organes [Hypertension in solid organ transplants].
Glatz N., Wuerzner G., Pruijm M., Golshayan D., Burnier M., 2009. Revue Médicale Suisse, 5 (216) pp. 1771-1777.
 
Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
Manuel O., Kumar D., Moussa G., Chen M.H., Pilewski J., McCurry K.R., Studer S.M., Crespo M., Husain S., Humar A., 2009. Transplantation, 87 (5) pp. 719-725.
 
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V., Venetz J.P., Pantaleo G., Pascual M., 2009. Human Immunology, 70 (8) pp. 580-583.
Lung transplantation for COPD - evidence-based?
Lahzami S., Aubert J.D., 2009. Swiss Medical Weekly, 139 (1-2) pp. 4-8. Peer-reviewed.
 
Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology.
Manuel O., Lien D., Weinkauf J., Humar A., Cobos I., Kumar D., 2009. Journal of Heart and Lung Transplantation, 28 (11) pp. 1231-1236.
Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability.
Golshayan D., Pascual M., Vogt B., 2009. Therapeutics and Clinical Risk Management, 5 (4) pp. 341-351. Peer-reviewed.
 
New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses.
Tapparel C., Junier T., Gerlach D., Van-Belle S., Turin L., Cordey S., Mühlemann K., Regamey N., Aubert J.D., Soccal P.M. et al., 2009. Emerging Infectious Diseases, 15 (5) pp. 719-726. Peer-reviewed.
No detectable indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frédéric, Manuel Oriol, Venetz Jean-Pierre, Faouzi Mohamed, Meylan Pascal, Pascual Manuel, 2009. pp. IMI-3, p. 62 dans Genes and Diseases, CHUV Research Day, January 29, 2009, Université de Lausanne, Faculté de biologie et de médecine.
 
Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD.
Meier P., Golshayan D., Blanc E., Pascual M., Burnier M., 2009. Journal of the American Society of Nephrology, 20 (6) pp. 1368-1384.
 
Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.
Perrottet N., Csajka C., Pascual M., Manuel O., Lamoth F., Meylan P., Aubert J.D., Venetz J.P., Soccal P., Decosterd L.A. et al., 2009. Antimicrobial agents and chemotherapy, 53 (7) pp. 3017-23.
 
Regulation of Rat and Human T-cell Immune Response by Pharmacologically Modified Dendritic Cells.
Fazekasova H., Golshayan D., Read J., Tsallios A., Tsang J.Y., Dorling A., George A.J., Lechler R.I., Lombardi G., Mirenda V., 2009. Transplantation, 87 (11) pp. 1617-1628.
 
Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults.
Garbino J., Soccal P.M., Aubert J.D., Rochat T., Meylan P., Thomas Y., Tapparel C., Bridevaux P.O., Kaiser L., 2009. Thorax, 64 (5) pp. 399-404.
 
Role of the naive and memory CD4+T-cell repertoire in transplantation
Golshayan D., Wyss J.C., Hernandez-Fuentes M., Pascual M., Lechler R., 2009. pp. 3S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Short-course thymoglobulin induction and steroid-free immunosuppressive regimen in renal transplantation
Hadaya K., Venetz J.P., Ponte B., Vallotton L., Buhler L., Pascual M., Martin P.Y., 2009. pp. 6S dans Annual meeting of the Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Suivi du patient après transplantation cardiaque: monitoring et adaptation de l'immunosuppression [Monitoring and adjustment of immunosuppression after heart transplantation].
Yerly P., Mach F., Kalangos A., Rotman S., von Segesser L., Vogt P., Hullin R., Pascual M., 2009. Revue Médicale Suisse, 5 (205) pp. 1214-1220.
 
T regulatory cells in xenotransplantation.
Muller Y.D., Golshayan D., Ehirchiou D., Wekerle T., Seebach J.D., Bühler L.H., 2009. Xenotransplantation, 16 (3) pp. 121-128. Peer-reviewed.
 
The role of I-123-hippuran(OIH) renography (RG) in the presurgical, work-up of laparoscopic live kidney donors : SS421
Nicod Lalonde M., Venetz J.P., Matter M., Qanadli S., Bischof Delaloye A., 2009. dans SGR-SSR 2009, 96th Annual Swiss Congress of Radiology.
 
The role of significant others in the course of transplantation through the patients points of view : a longitudinal study.
Bridy C., Bosisio F., Pralong L., Pascual M., Piot-Ziegler C., 2009. dans 14th ESOT Congress, European Society for Organ Transplantation. Peer-reviewed.
 
Time-Course In Vivo Trafficking Pattern and Effector Function of Donor-Specific Regulatory T Cells in Response to an Allograft.
Golshayan Dela, Wyss Jean-Christophe, Abulker Caroline Wyss, Schaefer Stephan, Lechler Robert I., Lehr Hans-Anton, Pascual Manuel, 2009. p. 541 dans 9th Joint Meeting of the American Society of Transplant Surgeon and of the American Society of Transplantation, American Journal of Transplantation. Peer-reviewed.
 
Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action.
Golshayan D., Wyss J.C., Abulker C.W., Schaefer S.C., Lechler R.I., Lehr H.A., Pascual M., 2009. International Immunopharmacology, 9 (6) pp. 683-688. Peer-reviewed.
 
Usefulness of a routine monitoring of cytomegalovirus viremia after discontinuation of antiviral prophylaxis in kidney transplantation : P117
Boillat N., Pascual M., Venetz J.P., Meylan P.R, Manuel O., 2009. pp. 31S dans Joint Annual Congress of the Swiss Society for Allergology and Immunology and the Swiss Society for Infectious Diseases, Swiss Medical Weekly. Peer-reviewed.
 
Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.
Perrottet N., Decosterd L.A., Meylan P., Pascual M., Biollaz J., Buclin T., 2009. Clinical Pharmacokinetics, 48 (6) pp. 399-418. Peer-reviewed.
 
Case Report: Human herpesvirus 6 reactivation associated with colitis in a lung transplant recipient
Lamoth F., Jayet P.Y., Aubert J.D., Rotman S., Mottet C., Sahli R., Lautenschlager I., Pascual M., Meylan P., 2008/10. Journal of Medical Virology, 80 (10) pp. 1804-1807.
Fabry nephropathy: 5 years of enzyme replacement therapy--a short review
Barbey F., Lidove O., Schwarting A., 2008/02/01. Clinical Kidney Journal, 1 (1) pp. 11-19.
 
Absence of BK viremia clearance after low-dose cidofovir therapy in kidney transplant recipients with BK virus associated nephropathy
Lamoth Frederic, Pascual Manuel, Nseir Ghaleb, Venetz Jean-Pierre, Meytan Pascal R., 2008. pp. S12-S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
Allograft Rejection in Kidney Transplantation
Pascual M., 2008. International Transplantation Updates, 10 141, Permanyer.
 
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
Bianchi E., Pascual M., Nicod M., Delaloye A.B., Duchosal M.A., 2008. Transplantation, 85 (5) pp. 707-712. Peer-reviewed.
 
Cost effectiveness of a new combined immunosuppressive and antiviral regimen on the one-year follow-up of kidney transplant patients.
Manuel Oriol, Kast-Bruechner Mira, Venetz Jean-Pierre, Meylan Pascal R., Pascual Manuel, Wasserfallen Jean-Blaise, 2008. pp. 395-395 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients.
Crettol S., Venetz J.P., Fontana M., Aubert J.D., Pascual M., Eap C.B., 2008. Therapeutic Drug Monitoring, 30 (6) pp. 689-699. Peer-reviewed.
 
Cytomegalovirus infection and new-onset post-transplant diabetes mellitus.
Leung Ki E.L., Venetz J.P., Meylan P., Lamoth F., Ruiz J., Pascual M., 2008. Clinical Transplantation, 22 (2) pp. 245-249.
 
Disposition of oral valganciclovir during continuous renal replacement therapy in two lung transplant recipients
Perrottet Nancy, Robatel Corinne, Meylan Pascal, Pascual Manuel, Venetz Jean-Pierre, Aubert John-David, Berger Mette M., Decosterd Laurent A., Biollaz Jerome, Buclin Thierry, 2008. p. 566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Disposition of valganciclovir during continuous renal replacement therapy in two lung transplant recipients.
Perrottet N., Robatel C., Meylan P., Pascual M., Venetz J.P., Aubert J.D., Berger M.M., Decosterd L.A., Buclin T., 2008. Journal of Antimicrobial Chemotherapy, 61 (6) pp. 1332-1335.
 
Existential questionings during the pretransplantation period: A qualitative phenomenological study
Piot-Ziegler C., Bonner Ruffiner N., Fasseur F., Santiago-Delefosse M., Pascual M., 2008. p. 30 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Existential values transformation in all organ transplantation: A qualitative prospective study.
Piot-Ziegler Chantal, Ruffiner-Boner Nadja, Cuttelod Therese, Fonjallaz Floriane, Pilon Nathalie, Pascual Manuel, 2008. p. 400 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Experimental Gene Therapy of Heart Transplantation
Vassalli G., Seydoux C., Vogt P., Pascual M., Von Segesser L.K., 2008. pp. - dans Ashan N. (eds.) Chronic allograft failure: natural history, pathophysiology, diagnosis and managements chap. 11, Landes Bioscience.
 
From dialysis to transplantation, illness experience and patients' concerns about future: A longitudinal qualitative study
Piot-Ziegler C., Szymanski J., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., 2008. p. 210 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
HCV infection after liver transplantation is associated with lower levels of alloreactive CD4+CD25+CD45RO+IL-7R+high+ T cells
Ciuffreda Donatella, Codarri Laura, Buhler Leo, Giostra Emiliano, Mentha Gilles, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 389 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Hepatitis C virus infection in haemodialysis and kidney transplant patients.
Baid-Agrawal S., Pascual M., Moradpour D., Frei U., Tolkoff-Rubin N., 2008. Reviews in Medical Virology, 18 (2) pp. 97-115. Peer-reviewed.
 
Immunosuppression and clinical tolerance of allografts
Golshayan D., Pascual M., 2008. pp. 125-141 dans Arias Rodriguez M. (eds.) Tolerancia y trasplante de organos, Drug Farma.
 
In vivo mechanisms leading to transplantation tolerance induced by regulatory T cells
Golshayan D., Wyss J.C., Wyss C., Schaefer S., Lechler R., Lehr H.A., Pascual M., 2008. pp. 6S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients
Crettol Séverine, Venetz Jean-Pierre, Fontana Massimiliano, Aubert John-David, Ansermot Nicolas, Fathi Marc, Pascual Manuel, Eap Chin-Bin, 2008. Pharmacogenetics and Genomics, 18 (4) pp. 307-315. Peer-reviewed.
 
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.
Lamoth Frederic, Pascual Manuel, Erard Veronique, Venetz Jean-Pierre, Nseir Ghaleb, Meylan Pascal, 2008. Antiviral Therapy, 13 (8) pp. 1001-1009. Peer-reviewed.
 
Low-dose valganciclovir is efficacious and safe for prophylaxis of cytomegalovirus infection in kidney transplantation
Perrottet Nancy, Manuel Oriol, Venetz Jean-Pierre, Lamoth Frederic, Decosterd Laurent A., Buclin Thierry, Biollaz Jerome, Meylan Pascal, Pascual Manuel, 2008. pp. 565-566 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.
Golshayan D., Pascual M., 2008. Transplant Immunology, 20 (1-2) pp. 21-28.
 
No detectable indirect effects of late-onset Cytomegalovirus disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Lamoth Frederic, Manuel Criol, Meylan Pascal R., Venetz Jean-Pierre, Faouzi Mohammed, Pascual Manuel, 2008. pp. S13 dans Abstracts of the 15th International Symposium on Infections in the Immunocompromised Host, International Journal of Infectious Diseases. Peer-reviewed.
 
No evidence of indirect effects of late-onset cytomegalovirus (CMV) disease after valganciclovir (VGC) prophylaxis in kidney transplant recipients
Manuel Oriol, Lamoth Frederic, Meylan Pascal R., Fellay Jacques, Venetz Jean-Pierre, Pascual Manuel, 2008. p. 527 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
Optimal prevention of late-onset cytomegalovirus (CMV) disease and other sequelae of CMV infection in organ transplant recipients - Reply
Legendre Christophe, Pascual Manuel, 2008. Clinical Infectious Diseases, 47 (2) pp. 297-298.
 
Patients' spontaneous discourse on the importance of significant others in the course of transplantation: A qualitative study
Bridy C., Ruffiner-Boner N., Fasseur F., Santiago M., Pascual M., Piot-Ziegler C., 2008. p. 73 dans Joint BPS (British Psychological Society's) Division of Health Psychology/European Health Psychology Society Annual Conference 2008, Psychology and Health.
 
Prevalence and significance of anti-HILA antibodies after liver transplantation : P236
Fontana M., Moradpour D., Aubert V., Estoppey M., Rotman S., Pascual M., 2008. pp. 54S-55S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Prevalence and significance of anti-HLA antibodies after liver transplantation
Fontana Massimiliano, Moradpour Darius, Aubert Vincent, Estoppey Michele, Rotman Samuel, Pascual Manuel, 2008. pp. S226-S227 dans 14th Annual International Congress of the International Liver Transplantation, Liver Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton Laure, Hadaya Karine, Ciuffreda Donatella, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Prospective monitoring of a CD4+ CD25high CD45RO+ CD127high T-cell population after first kidney transplantation following thymoglobulin or basiliximab induction
Vallotton L., Hadaya K., Buhler L., Ciuffreda D., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Psychological stakes before and after transplantation : a prospective qualitative study
Piot-Ziegler C., Ruffiner-Boner N., Cuttelod T., Fonjallaz F., Szymanski J., Fasseur F., Pilon N., Weigand I., Aubert JD., Pascual M., 2008., ATC Toronto Canada dans American Transplant Conference Book. Peer-reviewed.
 
Quality of life transformations before and after kidney transplantation: A prospective qualitative study.
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Weigand Isabelle, Santiago Marie, Venetz Jean-Pierre, Pascual Manuel, 2008. pp. 400-401 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Switch to Sirolimus-based immunosuppresion in stable renal transplant recipients
Nseir G., Venetz J.P, Hadaya K., Buhler L., Martin P.Y., Pascual M., 2008. pp. 18S dans 40th Annual Meeting Swiss Society of Nephrology, Swiss Medical Weekly. Peer-reviewed.
 
The presence of a CD4(+) CD25(high) CD45RO(+) CD127(high) T cell population correlates with the clinical status of kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Hadaya Karine, Buhler Leo, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2008. p. 473 dans 8th American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
The presence of a CD4+ CD25high CD45RO+ CD127high T-cell population correlates with the clinical status of kidney transplant recipients
Vallotton L., Codarri L., Ciuffreda D., Hadaya K., Buhler L., Venetz J.P., Pantaleo G., Pascual M., 2008. pp. 57S dans Annual Joint Meeting of the Swiss Societies for Pneumology, Paediatric Pneumology, Allergology and Immunology, Thoracic Surgery, Swiss Medical Weekly. Peer-reviewed.
 
Transplantation hépatique : introduction en Suisse d'un nouveau système d'allocation des organes [Liver transplantation: new organ allocation system in Switzerland]
Fontana M., Giostra E., Pilon N., Michetti P., Mentha G., Pascual M., Moradpour D., 2008. Revue Médicale Suisse, 4 (141) pp. 221-223.
 
Treatment of antibody-mediated rejection in kidney transplantation
Venetz J.P., Pascual M., 2008. EJHP Practice, 14 (5) pp. 21-24.
 
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007/12/01. Swiss medical weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin deficiency.
Manuel O., Tarr P.E., Venetz J.P., Trendelenburg M., Meylan P.R., Pascual M., 2007/09. Transplant Infectious Disease, 9 (3) pp. 214-218. Peer-reviewed.
 
Role du pathologiste dans la pathologie renale. [The crucial role of the pathologist in renal disease]
Rotman S., Venetz J. P., Vogt B., 2007/07. Revue Médicale Suisse, 3 (119) pp. 1723-5.
 
New treatments for acute humoral rejection of kidney allografts.
Venetz J.P., Pascual M., 2007/05. Expert Opinion on Investigational Drugs, 16 (5) pp. 625-633.
 
Cytomegalovirus in transplantation - challenging the status quo.
Fishman J.A., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., Sgarabotto D., Torre-Cisneros J., Uknis M.E., 2007/04. Clinical Transplantation, 21 (2) pp. 149-158.
 
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation.
Manuel O., Pascual M., Trendelenburg M., Meylan P.R., 2007/02. Transplantation, 83 (3) pp. 359-362. Peer-reviewed.
 
Association between mannose-binding lectin deficiency and cytornegalovirus infection course after organ transplantation.
Manuel Oriol, Pascual Manuel, Trendelenburg Marten, Muheim Carmen, Meylan Pascal R., 2007. p. 501 dans Annual American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation.
Fontana M., Ciuffreda D., Moradpour D., Pascual M., 2007. Transplantation, 83 (4) pp. 525-526.
 
Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation.
Manuel O., Humar A., Preiksaitis J., Doucette K., Shokoples S., Peleg A.Y., Cobos I., Kumar D., 2007. American Journal of Transplantation, 7 (12) pp. 2797-2801. Peer-reviewed.
 
Cost-effectiveness of a new combined immunosupressive regimen in kidney transplantation
Wasserfallen Jean-Blaise, Kast-Brückner Mira, Manuel Oriol, Venetz Jean-Pierre, Meylan Pascal, Pascual Manuel, 2007. pp. 40S dans Annual Conference of the Swiss Respiratory Society, Swiss Medical Weekly. Peer-reviewed.
 
Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
Ciuffreda D., Pantaleo G., Pascual M., 2007. Transplant International, 20 (8) pp. 649-658. Peer-reviewed.
Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation.
Manuel O., Venetz J.P., Fellay J., Wasserfallen J.B., Sturzenegger N., Fontana M., Matter M., Meylan P.R., Pascual M., 2007. Swiss Medical Weekly, 137 (47-48) pp. 669-676. Peer-reviewed.
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients.
Codarri L., Vallotton L., Ciuffreda D., Venetz J.P., Garcia M., Hadaya K., Buhler L., Rotman S., Pascual M., Pantaleo G., 2007. Journal of Experimental Medicine, 204 (7) pp. 1533-1541. Peer-reviewed.
 
From current immunosuppressive strategies to clinical tolerance of allografts.
Golshayan D., Buhler L., Lechler R.I., Pascual M., 2007. Transplant International, 20 (1) pp. 12-24. Peer-reviewed.
Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats.
Simeoni E., Dudler J., Fleury S., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2007. European Journal of Cardio-thoracic Surgery, 31 (2) pp. 222-228. Peer-reviewed.
 
Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
Dudler J., Simeoni E., Fleury S., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2007. Transplant International, 20 (5) pp. 460-466. Peer-reviewed.
 
Homeostasis and in vivo effector function of antigen-specific CD4+CD25+ regulatory T cells in experimental transplantation.
Golshayan Dela, Schaefer Stephan, Jiang Shuiping, Pascual Manuel, Lehr Hans-Anton, Lechler Robert I., 2007. p. 172 dans Annual American Transplant Congress, American Journal of Transplantation. Peer-reviewed.
 
Identification of an expanded population of activated CD4(+) CD25(+) T cells expressing CD45RO and IL-7R in kidney transplant recipients
Vallotton Laure, Codarri Laura, Ciuffreda Donatella, Venetz Jean-Pierre, Pantaleo Giuseppe, Pascual Manuel, 2007. p. 153 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
Identification of an expanded population of activated CD4(+)CD25(+)CD45RO(+)IL-7R(+) T cells in liver transplant recipients: downmodulation by HCV
Ciuffreda D., Codarri L., Pascual M., Pantaleo G., 2007. pp. 18S dans Annual Conference Swiss Society for Allergology and Immunology, Spring Meeting Swiss Society of Dermatology and Venerology, Swiss Medical Weekly. Peer-reviewed.
 
Oral valganciclovir for cytomegalovirus colitis after liver transplantation.
Manuel O., Meylan P.R., Rotman S., Fontana M., Moradpour D., Pascual M., 2007. Transplantation, 83 (2) pp. 239-240. Peer-reviewed.
 
Pharmacokinetic and pharmacodynamic assessement of valganciclovir in the prophylaxis and treatment of CMV disease in solid organ transplant patients
Manuel O., Perrottet N., Lamoth F., Venetz J.P., Decosterd L.A., Buclin T., Pascual M., Meylan P., 2007. pp. 9S dans Annual Conference Swiss Society for Paediatrics, Swiss Medical Weekly. Peer-reviewed.
 
Psychological transformations in kidney transplantation: A prospective qualitative study
Piot-Ziegler Chantal, Szymanski Jennifer, Ruffiner-Boner Nadja, Fasseur Fabienne, Maillefer Julia, Weigand Isabelle, Venetz Jean-Pierre, Santiago Marie, Pascual Manuel, 2007. p. 181 dans 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization, Transplant International. Peer-reviewed.
 
Drug-minimization or tolerance-promoting strategies in human kidney transplantation: is Campath-1H the way to follow?
Golshayan D., Pascual M., 2006/11. Transplant International, 19 (11) pp. 881-4.
 
Comparison of two dosages of thymoglobulin used as a short-course for induction in kidney transplantation
Wong W., Agrawal N., Pascual M., Anderson D. C., Hirsch H. H., Fujimoto K., Cardarelli F., Winkelmayer W. C., Cosimi A. B., Tolkoff-Rubin N., 2006/08. Transplant International, 19 (8) pp. 629-35. Peer-reviewed.
Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model
Li J., Simeoni E., Fleury S., Dudler J., Fiorini E., Kappenberger L., von Segesser L. K., Vassalli G., 2006/05. European Journal of Cardio-Thoracic Surgery, 29 (5) pp. 779-83.
Anti-HLA antibody repertoire after IVIg infusion in highly sensitized patients waiting for kidney transplantation.
Ferrari-Lacraz Sylvie, Aubert Vincent, Buhler Leo, Pascual Manuel, Andresen Irmgard, Binet Isabelle, Martin Pierre-Yves, Villard Jean, 2006. Swiss Medical Weekly, 136 (43-44) pp. 696-702.
 
Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
Dudler J., Li J., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G., 2006. Transplantation, 82 (12) pp. 1733-7. Peer-reviewed.
 
Maladies inflammatoires cryptogéniques de l'intestin de novo après transplantation hépatique: rapport de quatre nouveaux cas et revue de la littérature [De novo inflammatory bowel diseases after liver transplantation: description of four new cases and a review of the literature]
Vu F., Maillard M., Pascual M., Michetti P., Felley C., 2006. Gastroentérologie clinique et biologique, 30 (8-9) pp. 1096-101. Peer-reviewed.
 
Meningococcal disease in a kidney transplant recipient with mannose-binding lectin (MBL) deficiency
Manuel O., Tarr R., Venetz J.P., Trandelenburg M., Meylan P., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
 
Oral valganciclovir prophylaxis in kidney transplant recipients
Manuel O., Fellay J., Venetz J.P., Sturzenegger N., Meylan R., Pascual M., 2006. pp. S16 dans 12th International Society for infectious Diseases, International Journal of Infectious Diseases. Peer-reviewed.
Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan P.R., Pascual M., 2006. Clinical Infectious Diseases, 43 (7) pp. 881-883. Peer-reviewed.
 
Sensitization after kidney transplantation.
Akalin E., Pascual M., 2006. Clinical Journal of the American Society of Nephrology, 1 (3) pp. 433-440.
 
Humoral rejection of organ allografts.
Moll S., Pascual M., 2005/11. American Journal of Transplantation, 5 (11) pp. 2611-2618.
 
2005 immunosuppressive strategies in kidney transplantation: which role for the calcineurin inhibitors?
Wong W., Venetz J.P., Tolkoff-Rubin N., Pascual M., 2005/08. Transplantation, 80 (3) pp. 289-296.
 
Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
Cardarelli F., Pascual M., Tolkoff-Rubin N., Delmonico F.L., Wong W., Schoenfeld D.A., Zhang H., Cosimi A.B., Saidman S.L., 2005/05. Transplant International, 18 (5) pp. 532-540.
 
Chirurgie viscérate chez le patient greffé ou en attente d'une transplantation [Visceral surgery in organ transplant recipients or in patients awaiting transplantation].
Matter M., Saucy F., Venetz J.P., Pascual M., 2005. Revue Médicale Suisse, 1 (24) pp. 1608-1615.
 
Options chirurgicates pour l'insuffisance cardiaque terminale [Surgical options for terminal heart failure]
von Segesser L.K., Fischer A., Vassalli G., Jeanrenaud X., Gersbach P., Seydoux C., Hurni M., Eeckhout E., Ruchat P., Kappenberger L. et al., 2005. Revue médicale suisse, 1 (21) pp. 1432-7.
 
Sirolimus-induced acneiform eruption.
Kunzle N., Venetz J.P., Pascual M., Panizzon R.G., Laffitte E., 2005. Dermatology, 211 (4) pp. 366-369.
 
The experience of transplantation for patients and their significant ones: A difficult encounter of two worlds
Piot-Ziegler C., Ruffiner-Boner N., Fasseur F., Demierre M., Castelao E., Ben Sassi M.L., Pascual M., 2005. p. 217 dans 19th Annual Conference of the European Health Psychology Society (EHPS), Psychology and Health.
 
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
Fellay J., Venetz J.P., Aubert J.D., Seydoux C., Pascual M., Meylan P.R., 2005. Transplantation Proceedings, 37 (2) pp. 949-951. Peer-reviewed.
 
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.
Fellay J., Venetz J.P., Pascual M., Aubert J.D., Seudoux C., Meylan P.R., 2005. American Journal of Transplantation, 5 (7) pp. 1781-2; author reply 1783.
 
Urological complications in renal transplantation from cadaveric donor grafts: a retrospective analysis of 20 years.
Praz V., Leisinger H.J., Pascual M., Jichlinski P., 2005. Urologia internationalis, 75 (2) pp. 144-9. Peer-reviewed.
 
Hepatitis C, acute humoral rejection, and renal allograft survival
Forman J. P., Tolkoff-Rubin N., Pascual M., Lin J., 2004/12. Journal of the American Society of Nephrology, 15 (12) pp. 3249-55. Peer-reviewed.
 
Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies
Cardarelli F., Pascual M., Chung R. T., Tolkoff-Rubin N., Wong W., Cosimi A. B., Saidman S. L., 2004/08. American Journal of Transplantation, 4 (8) pp. 1352-6. Peer-reviewed.
 
Update in renal transplantation.
Magee C.C., Pascual M., 2004/07. Archives of Internal Medicine, 164 (13) pp. 1373-1388.
 
Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients
Baid-Agrawal S., Delmonico F. L., Tolkoff-Rubin N. E., Farrell M., Williams W. W., Shih V., Auchincloss H., Cosimi A. B., Pascual M., 2004/04. Transplantation, 77 (8) pp. 1199-202. Peer-reviewed.
 
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.
Wong W., Tolkoff-Rubin N., Delmonico F.L., Cardarelli F., Saidman S.L., Farrell M.L., Shih V., Winkelmayer W.C., Cosimi A.B., Pascual M., 2004. Clinical Transplantation, 18 (4) pp. 341-348.
 
Bilan préopératoire pour la chirurgie cardio-vasculaire en urgence [Preoperative assessment in emergency cardiovascular surgery].
von Segesser L.K., Chassot P.G., Corno A., Bernath M., Tozzi P., Marty B., Ruchat P., Gersbach P., Pascual M., Fischer A. et al., 2004. Revue Médicale de la Suisse Romande, 124 (7) pp. 395-399.
 
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients
Goggins W. C., Pascual M. A., Powelson J. A., Magee C., Tolkoff-Rubin N., Farrell M. L., Ko D. S., Williams W. W., Chandraker A., Delmonico F. L. et al., 2003/09. Transplantation, 76 (5) pp. 798-802. Peer-reviewed.
 
A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation
Pascual M., Curtis J., Delmonico F. L., Farrell M. L., Williams, W. W., Jr. , Kalil R., Jones P., Cosimi A. B., Tolkoff-Rubin N., 2003/05. Transplantation, 75 (9) pp. 1501-5. Peer-reviewed.
A pregnant woman with de novo polyuria-polydipsia and elevated liver enzymes.
Barbey F., Bonny O., Rothuizen L., Gomez F., Burnier M., 2003. Nephrology, Dialysis, Transplantation, 18 (10) pp. 2193-2196.
 
Pneumologie : corticostéroïdes inhalés dans la BPCO : traitement pharmacologique de l'hypertension pulmonaire : acquisitions thérapeutiques 2002
Sauty Alain, Aubert John-David, Rochat T, 2003/01/01. Médecine et hygiène, 61 (2419) pp. 49-55.
 
Protéinurie orthostatique et phénomène de compression de la veine rénale gauche (nutcracker syndrome) [Orthostatic proteinuria and compression of the left renal vein (nutcracker syndrome)]
Barbey F., Venetz J.P., Calderari B., Nguyen Q.V., Meuwly J.Y., 2003. Presse Médicale, 32 (19) pp. 883-885. Peer-reviewed.
 
L'insuffisance rénale et le complément
Pascual M., Schifferli J.A., 1991. Médecine et Hygiène, 49 (1876) pp. 504-513.
 
Le facteur D du complément: toxine urémique [Factor D of complement: Uremic toxin?].
Pascual M., 1991. Néphrologie, 12 (5) pp. 215-219. Peer-reviewed.
 
Déficits en complément: complications infectieuses méningées.
Pascual M., Schifferli J.A., 1988. Médecine et Hygiène, 46 (1737) pp. 536-541.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University